Crystal structures of agonist-bound human cannabinoid receptor CB<sub>1</sub>.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 40866700.
- Also identified by DOI 10.1038/s41586-025-09454-5 and PMC identifier 12935026.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Cannabinoid receptor 1 (CB<sub>1</sub>) is the primary target of the partial agonist Δ<sup>9</sup>-tetrahydrocannabinol (Δ<sup>9</sup>-THC), the psychoactive constituent of marijuana<sup>1</sup>. Here we report two agonist-bound crystal structures of human CB<sub>1</sub> in complex with a tetrahydrocannabinol (AM11542) and a hexahydrocannabinol (AM841). The two CB<sub>1</sub>-agonist complexes reveal important conformational changes in the overall structure relative to the antagonist-bound state<sup>2</sup>, including a 53% reduction in the volume of the ligand-binding pocket and an increase in the surface area of the G protein-binding region. Furthermore, a twin toggle switch of Phe200<sup>3.36</sup> and Trp356<sup>6.48</sup> (where the superscripts denote Ballesteros-Weinstein numbering<sup>3</sup>) is experimentally observed and seems to be essential for receptor activation. The structures reveal important insights into the activation mechanism of CB<sub>1</sub> and provide a molecular basis for predicting the binding modes of Δ<sup>9</sup>-THC, and endogenous and synthetic cannabinoids. The plasticity of the binding pocket of CB<sub>1</sub> seems to be a common feature among certain class A G protein-coupled receptors. These findings should inspire the design of chemically diverse ligands with distinct pharmacological properties.
Medical subject headings
- Receptor, Cannabinoid, CB1
- Dronabinol
- Cannabinoid Receptor Agonists